GEN’s Jonathan Grinstein, PhD, and Alex Philippidis discuss Day 2 of the J.P. Morgan 41st Healthcare Conference being held in San Francisco, focusing on the executives and investment leaders they interviewed. Among investment leaders were Vijay Pande, PhD, of Andreessen Horowitz (a16z); Samir Kaul of Khosla Ventures; and Tom Burt, EngD of Soffinova Partners. Jonathan and Alex also discuss the companies whose leaders they also interviewed, including Alto Neuroscience, Bayer Oncology, and Vor Bio.

Previous articleUncovering the Link between Obesity and Diabetes Risk
Next articleReporter’s Notebook: On Day 2 of J.P. Morgan, Start-Ups Soliciting Cash and VCs Eschewing High Risk